Diversity of beta-lactam resistance levels among related Klebsiella pneumoniae strains isolated in an intensive care unit

Journal of Chemotherapy

Volumn 12, Issue 3, 2000, Pages 204-207

  Paniara, Olga ^b   Platsouka, E ^c   Dimopoulou, H ^c   Tzelepi, E ^c   Miriagou, V ^c   Tzouvelekis, L S ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b EVANGELISMOS HOSPITAL   (Greece)

^c NONE

Author keywords

Beta lactams; Epidemiology; Klebsiella pneumoniae; Resistance

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AZTREONAM; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CLAVULANIC ACID; IMIPENEM; PIPERACILLIN PLUS TAZOBACTAM; TIMENTIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; HOSPITAL INFECTION; INTENSIVE CARE UNIT; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN;

EID: 0034131407     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2000.12.3.204     Document Type: Article

References (11)

1. 1 Legakis NJ, Tzouvelekis LS, Tsakris A, Legakis JN, Vatopoulos AC. On the incidence of antibiotic resistance among Gram-negative rods isolated in Greek hospitals. J Hosp Infect 1993; 24: 233-237.
2. 2 Vatopoulos AC, Philippon A, Tzouvelekis LS, Komninou Z, Legakis NJ. Prevalence of a transferable SHV-5 type beta-lactamase in clinical isolates of Klebsiella pneumoniae and Escherichia coli in Greece. J Antimicrob Chemother 1990; 26: 635-648.
3. 3 Legakis NJ, Tzouvelekis LS, Hatzoudis G, et al. Klebsiella pneumoniae infections in Greek hospitals. Dissemination of plasmids encoding an SHV-5 type beta-lactamase. J Hosp Infect 1995; 31: 177-187.
4. 4 Prinarakis EE, Tzelepi E, Gazouli M, Mentis AF, Tzouvelekis LS. Characterization of a novel SHV beta-lactamase variant that resembles the SHV-5 enzyme. FEMS Microbiol Lett 1996; 139: 229-234.
5. 5 Hulton CS, Higgins CF, Sharp PM. ERIC sequences: a novel family of repetitive elements in the genomes of Escherichia coli, Salmonella typhimurium and other enterobacteria. Mol Microbiol 1991; 5: 825-834.
6. 6 Livermore DM. Beta-lactamases in laboratory and clinical resistance. Clin Microbiol Rev 1995; 8: 557-584.
7. 7 Gazouli M, Kaufmann ME, Tzelepi E, Dimopoulou H, Paniara O, Tzouvelekis LS. Study of an outbreak of cefoxitin-resistant Klebsiella pneumoniae in a general hospital. J Clin Microbiol 1997; 35: 508-510.
8. 8 Medeiros AA. Evolution and dissemination of beta-lactamases accelerated by generations of beta-lactam antibiotics. Clin Infect Dis 1997; 24(Suppl 1): 19-45.
9. 9 French GL, Shannon KP, Simmons N. Hospital outbreak of Klebsiella pneumoniae resistant to broad-spectrum cephalosporins and beta-lactam-beta-lactamase inhibitor combinations by hyperproduction of SHV-5. J Clin Microbiol 1996; 34: 358-363.
10. 10 Tzouvelekis LS, Tzelepi E, Prinarakis E, et al. Sporadic emergence of Klebsiella pneumoniae strains resistant to cefepime and cefpirome in Greek hospitals. J Clin Microbiol 1998; 36: 266-268.
11. 11 Martinez-Martinez L, Hernadez-Ales S, Alberti S, Tomas JM, Benedi VJ, Jacoby GA. In vivo selection of porindeficient mutants of Klebsiella pneumoniae with increased resistance to cefoxitin and expanded-spectrum cephalosporins. Antimicrob Agents Chemother 1996; 40: 342-348.